Results 201 to 210 of about 259,590 (298)

Multivitamins,Nutrition,and Antiretroviral Therapy for HIV Disease in Africa [PDF]

, 2004
Cock, De, M, Kevin, Marston, Barbara
core  

Supporting long‐term engagement in HIV clinical care: Learning from the COVID‐19 pandemic

HIV Medicine, Volume 27, Issue 5, Page 678-689, May 2026.
Abstract Objectives SHIELD is a London‐based study of engagement in HIV clinical care during and after the COVID‐19 pandemic. We document the characteristics of service users who either re‐engaged or disengaged with HIV care, together with reflections of HIV clinical service‐providers to inform recommendations that address care retention for the long ...
R. Dhairyawan, Sara Paparini, M. Smuk, S. Sidat, R. Mbewe, Silvia Petretti, V. Martin, S. Dakshina, H. Alexander, T. D. Appleby, K. Childs, M. Bracchi, B. Dragovic, G. Haidari, N. Mackie, I. Reeves, A. Umaipalan, L. J. Waters, J. Anderson, C. M. Orkin   +19 more
wiley   +1 more source

Multifactorial determinants of lost to follow-up in antiretroviral therapy: evidence from a case-control study in Mexico. [PDF]

AIDS Res Ther
Del Moral Trinidad LE, Hernández LAG, Villanueva JFA, Lara FA, Quiñones SZ, Herrera VVR, Valle Rodríguez A, Reyes KS, Zavala MA, Sánchez GAA, Martínez Ayala P.   +10 more
europepmc   +1 more source

Hierarchical analysis of unsuccessful tuberculosis treatment among people living with HIV in Brazil using nationwide surveillance data

HIV Medicine, Volume 27, Issue 5, Page 710-726, May 2026.
Abstract Introduction People with tuberculosis‐HIV coinfection face multiple barriers to effective treatment, including social vulnerability, stigma and limited access to healthcare. This study examined factors associated with loss to follow‐up and death among individuals with tuberculosis‐HIV in Brazil.
Lucas Vinícius de Lima, Gabriel Pavinati, Francisco Beraldi‐Magalhães, Rubia Laine de Paula Andrade‐Gonçalves, Aline Aparecida Monroe, Marcela Demitto Furtado, Rosana Rosseto de Oliveira, Daniele Maria Pelissari, Kleydson Bonfim Andrade Alves, Gabriela Tavares Magnabosco   +9 more
wiley   +1 more source

Recent Advances in HIV/AIDS Prevention: Focusing on Antiretroviral Therapy. [PDF]

Jugan Geongang Gwa Jilbyeong
Kim JH.
europepmc   +1 more source

Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV

HIV Medicine, Volume 27, Issue 5, Page 727-739, May 2026.
Abstract Introduction Long‐acting injectable antiretroviral therapy (ART) with Cabotegravir (CAB) and Rilpivirine (RPV) offers an alternative to daily oral regimens, improving adherence and patient satisfaction. However, its impact on body composition and metabolism remains underexplored.
Andrea De Vito, Andrea Marongiu, Antonella Cano, Mariangela Puci, Agnese Colpani, Susanna Maria Nuvoli, Maria Grazia Catte, Giulia Moi, Maria Antonietta Deledda, Sergio Uzzau, Giovanni Sotgiu, Franca Deriu, Angela Spanu, Giordano Madeddu   +13 more
wiley   +1 more source

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir‐based antiretroviral therapy

HIV Medicine, Volume 27, Issue 5, Page 803-808, May 2026.
Abstract Background Darunavir‐based antiretroviral therapy (ART) is commonly used in people with HIV who experience adherence challenges and/or have complex resistance patterns. Changes in ART commissioning have led to an increased use of Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in these populations despite limited real‐world outcome ...
Rhianna Sheridan, Yasmin Osei‐Kuffour Ekert, Lucy Campbell, Mark Zuckerman, Sally Hawkins, Kate Childs, Frank A. Post   +6 more
wiley   +1 more source

HIV infection during pregnancy: antiretroviral therapy and the associations with migrant status. [PDF]

BMC Public Health
Liu Z, Dong K, Sun M, Lin D, Chen Y, Zhang X.   +5 more
europepmc   +1 more source

Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system

HIV Medicine, Volume 27, Issue 5, Page 749-760, May 2026.
Abstract Objective Integrase strand transfer inhibitors (INSTIs) are widely used in antiretroviral therapy (ART) for people with HIV due to their efficacy and tolerability. However, concerns about weight gain and metabolic disturbances have emerged.
Leidan Zhang, Ling Chen, Jia Tang, Xiaosheng Liu, Liyuan Zheng, Fada Wang, Xin Huang, Wei Cao, Taisheng Li   +8 more
wiley   +1 more source

Clinical Consequences of Delaying Implementation of Long-Acting Antiretroviral Therapy for People With HIV and Persistent Viremia in the United States. [PDF]

Clin Infect Dis
Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle EP, Freedberg KA.   +13 more
europepmc   +1 more source